Skip to content

Is it safe to discontinue antibiotics in pediatric bacterial meningitis when patients still with low cerebrospinal fluid pleocytosis?

Is it safe to discontinue antibiotics in pediatric bacterial meningitis when patients still with low cerebrospinal fluid pleocytosis?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012884
Enrollment
Unknown
Registered
2017-10-04
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial meningitis

Interventions

A:Conventional antibiotics treatment until normalization of cerebrospinal-fluid cell profile
B:Sufficient conventional antibiotics treatment until other indeces normalization except cerebrospinal-fluid cell profile

Sponsors

The second affiliated hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Positive cerebrospinal-fluid culture or latex agglutination for H influenzae, S pneumoniae, and N meningitides; 2. More than 20 white blood cells per mL for baby (younger than 1 years old) or 10 for older children (older than 1 years old) of cerebrospinal fluid, with positive blood culture for the same organisms by day 3 of admission; 3. Cerebrospinal-fluid culture and latex agglutination both negative, but more than 100 white blood cells per mL with more than 50% granulocytes and cerebrospinal-fluid glucose less than 50% of blood glucose or less than 1.66 mmol/L; 4. More than 1000 white blood cells per mL of cerebrospinal fluid with 75% polymorphonuclear cells.

Exclusion criteria

Exclusion criteria: Exclusion criteria at enrolment 1. Children bodyweight 3kg or less; 2. Pre-existing neurosurgical conditions; 3. Seizure disorders, cerebral palsy, degenerative neurological disorders; 4. Cranial fractures; 5. Known immunodeficiency states, symptomatic AIDS; 6. Known hypersensitivity to cephalosporins; 7. Cyanotic congenital heart disease.

Design outcomes

Primary

MeasureTime frame
rate of relapse;

Countries

China

Contacts

Public ContactZhongdong Lin

The second affiliated hospital of Wenzhou Medical University

wzlzhd@163.com+86 13957713578

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026